SIGNATUREFD, LLC - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 187 filers reported holding AGIOS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.97 and the average weighting 0.1%.

Quarter-by-quarter ownership
SIGNATUREFD, LLC ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$16,607
-20.6%
671
-9.2%
0.00%
-100.0%
Q2 2023$20,928
+18.8%
739
-3.7%
0.00%
Q1 2023$17,618
-36.0%
767
-21.8%
0.00%
-100.0%
Q4 2022$27,546
-1.6%
981
-2.2%
0.00%0.0%
Q3 2022$28,000
+133.3%
1,003
+92.5%
0.00%
Q2 2022$12,000
+300.0%
521
+337.8%
0.00%
Q1 2022$3,000
+200.0%
119
+164.4%
0.00%
Q4 2021$1,000
-66.7%
45
-38.4%
0.00%
Q3 2021$3,000
-70.0%
73
-59.0%
0.00%
Q2 2021$10,000
+66.7%
178
+61.8%
0.00%
Q1 2021$6,000
+100.0%
110
+50.7%
0.00%
Q4 2020$3,0000.0%730.0%0.00%
Q3 2020$3,000
+50.0%
73
+92.1%
0.00%
Q2 2020$2,000
+100.0%
38
+5.6%
0.00%
Q1 2020$1,000
-66.7%
36
-33.3%
0.00%
Q4 2019$3,000
+200.0%
54
+200.0%
0.00%
Q3 2019$1,000
-50.0%
18
-63.3%
0.00%
Q2 2019$2,0000.0%49
+75.0%
0.00%
Q1 2019$2,000280.00%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Rock Springs Capital Management LP 3,057,869$86,477,0002.23%
Eagle Health Investments LP 329,713$9,324,0002.14%
Bellevue Group AG 4,058,792$114,783,0001.65%
SUVRETTA CAPITAL MANAGEMENT, LLC 959,214$27,127,0001.13%
ARMISTICE CAPITAL, LLC 1,924,000$54,411,0000.94%
Integral Health Asset Management, LLC 100,000$2,828,0000.55%
Monarch Partners Asset Management LLC 57,820$1,635,0000.49%
ArrowMark Colorado Holdings LLC 1,380,389$39,037,0000.48%
AlphaCentric Advisors LLC 15,000$424,0000.44%
PDT Partners, LLC 72,778$2,058,0000.31%
View complete list of AGIOS PHARMACEUTICALS INC shareholders